None listed
Conditions
Interventions
Dietary Supplement : Visit 1(week -2), subject who voluntarily signs on the written informed consent is reviewed according to inclusion-exclusion criteria. After run-in period, selected subject is ran
Sponsors
Amicogen
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subject who voluntarily agree to participate and signs informed consent form 2) 40 = age(men and women) < 65 3) 25kg/? = BMI < 33kg/? 4) waist circumference = 90 cm (male), = 85 cm (female) 5) Subject who can comply with diet and exercise guidelines during the arbitration period
Exclusion criteria
Exclusion criteria: 1) Subject who consistently took medications that affect body weight, lipids, blood sugar metabolism, immune and inflammatory reactions, and intestinal health within one month of the first visit or are likely to take them during the study period 2) Subject who has consumed of dietary supplements or oriental medicine affect body weight, lipid, blood sugar metabolism, immune and inflammatory reactions within one month before the first visit 3) Subject who constantly consumed foods (included health functional foods) related to affect Intestinal health before the first visit 4) Subject with following disease: Uncontrolled Hypertension, Liver dysfunction, Renal dysfunction, et al. 5) Participation in commercial obesity program or experience of calorie-restricted theraphy within three months before the first visit 6) Subject who has had a weight change of more than 5% within three months before the first visit 7) Subject with surgical experience (esophagogastroplasty, enterectomy, et al.) for weight loss 8) Subject who constantly exercised high-intensity as usual 9) Participation in other human study within 1 month before the first visit 10) Pregnant and lactating women 11) Subjects with hypersensitivity to test materials 12) Any condition that the principal investigator believes may put the subjects at undue risk
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body fat mass(Dual Energy X-Ray AbsorptiometryA) | — |
Secondary
| Measure | Time frame |
|---|---|
| Fat free mass, body fat percent etc.(Dual Energy X-Ray Absorptiometry);abdominal fat area(Computed Tomography );Body measurement;Related Metabolic indicators: blood lipid, glucose etc.;Bowel habits questionnaire;Food retention questionnaire | — |
Countries
Korea, Republic of
Contacts
Public ContactBelong Cho
Seoul National University Hospital
Outcome results
None listed